IE
VERA icon

Israel Englander’s Vera Therapeutics VERA Stock Holding History

Israel Englander’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,500
Closed -$372K – 6349
2025
Q1 		$372K Buy
+15,500
New +$498K ﹤0.01% 4985
2023
Q3 		– Sell
-20,000
Closed -$321K – 6602
2023
Q2 		$321K Buy
+20,000
New +$181K ﹤0.01% 4838

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Israel Englander's VERA Position: Q2 2026 in Review

Israel Englander reduced its Vera Therapeutics (VERA) stake by 5.1% in Q2 2026, selling an estimated $553K and leaving 278,658 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #2105.

Israel Englander first reported a position in VERA in Q2 2021 and has held it in 17 quarters since. The position peaked at $21.5M in Q4 2022. 218 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Israel Englander held 278,658 shares of Vera Therapeutics worth $12M as of Q2 2026.
  • Israel Englander sold 14,839 Vera Therapeutics shares in Q2 2026, an estimated $553K.
  • Vera Therapeutics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2105 holding.
  • Israel Englander first reported a position in Vera Therapeutics in Q2 2021 and has held it in 17 quarters since.
  • Israel Englander's Vera Therapeutics position peaked at $21.5M in Q4 2022.
  • 218 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.